(Q44189751)

English

Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases

scientific article published on 5 September 2002

Statements

Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases (English)
Markus Warmuth
Nicola Simon
Olga Mitina
Ruth Mathes
Doriano Fabbro
Paul W Manley
Elisabeth Buchdunger
Karin Forster
Ismail Moarefi
5 September 2002
664-672

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit